Skip to main content
Premium Trial:

Request an Annual Quote

That'll Encourage Them to Report Conflicts

In the wake of the conflict of interest hoopla at JAMA, the journal has set a new policy regarding complaints.

Lincoln Memorial University's Jonathan Leo had posted a letter at the British Medical Journal's website that criticized a JAMA study from last spring because it left out a key finding and because the lead author had a financial relationship with Forest Laboratories, the maker of the drug under study. JAMA editor in chief Catherine DeAngelis says in an editorial that her comment, cited in the Wall Street Journal, calling Leo "a nobody and a nothing" was erroneously reported. That editorial, co-authored by the journal's executive deputy editor Phil Fontanarosa, adds that by posting his BMJ letter and contacting the media that Leo made a "serious ethical breach of confidentiality" and that he "should not plan to submit future manuscripts or letters for publication."

The editorial also outlined JAMA's new policy: "JAMA will require that the individual bringing the allegations provide a written detailed explanation of the unreported conflicts of interest and provide documentation to support the allegation. The person bringing the allegation will be specifically informed that he/she should not reveal this information to third parties or the media while the investigation is under way, will be informed about progress of the investigation, upon request, as appropriate, and will be notified when the investigation is completed."

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.